Document is current
Any future updates will be listed below
-
Authors
Aiesh, Banan M.
Saleh, Salsabeel
Matouk, Nadine
Labadi, Marah
Kmail, Sanaa
Baddad, Zaina
Koni, Amer A.
Al-Jabi, Samah W.
Zyoud, Sa’ed H.
- License Information
-
More Information
Article History
Received: 21 October 2023
Accepted: 5 September 2024
First Online: 14 September 2024
Declarations
:
: The present study received approval from the <i>Institutional Review Board (IRB) of An-Najah National University</i> (Ref: Pharm D. Sep. 2022/34). In accordance with the principles of informed consent, the act of survey completion was construed as a manifestation of participants’ consent, given that the survey was distributed via online platforms utilizing a SurveyMonkey<sup>®</sup> account. Information concerning voluntary participation and the right to withdraw from the study was provided within the invitation, prominently displayed on the cover page. The cover page additionally elucidated the study’s objectives and provided guidance on how to respond to the survey questions. The data collected during the course of this study were exclusively utilized for research purposes and were diligently safeguarded to ensure anonymity and confidentiality. Participants were not provided with any form of incentive to motivate their survey participation. The IRB of An-Najah National University deemed it appropriate to waive the necessity for written informed consent, as the study was considered to pose minimal risk, and all procedures adhered rigorously to pertinent guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.
